Topas Therapeutics GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2006-01-01
- Employees
- 51
- Market Cap
- -
A Study to Assess the Safety of TPM502 in Adults With Celiac Disease
- First Posted Date
- 2022-12-21
- Last Posted Date
- 2024-05-28
- Lead Sponsor
- Topas Therapeutics GmbH
- Target Recruit Count
- 42
- Registration Number
- NCT05660109
- Locations
- 🇦🇺
Wesley Research Institute, Brisbane, Australia
🇦🇺Royal Adelaide Hospital, Adelaide, Australia
🇫🇮CRST Oy, Turku, Finland
© Copyright 2025. All Rights Reserved by MedPath